Zimbabwe relies on imports for drugs and hospital consumables. It imports about $400 million worth of basic drugs each year.
PHARMACEUTICALS manufacturing firm, MedTech Holdings, has warned of a looming drugs shortage after it failed to access foreign currency from the Reserve Bank of Zimbabwe (RBZ) to import critical medicines. This is premium content. Subscribe to read article.
MedTech is a diversified group of companies that manufactures, markets and distributes health, hygiene, beauty and pharmaceutical products. In a statement accompanying the company’s financial results for the year to December 31, 2017, MedTech said Zimbabweans should brace for drug shortages if the foreign currency shortages continue.Subscribe to The Financial Gazette